For instance, the expression of ZNF71 overall and its isoforms was not significantly different in NSCLC patient tumors separated by median ZEB1 expression (the top 50% ZEB1 expression group versus the bottom 50% ZEB1 expression group, two-sample t-tests; results not shown). This evidence concerns the gene ZEB1 and non-small cell lung carcinoma.